Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04426812 · ClinicalTrials.gov registry record

Measuring Chronic Pain Impact: Measurement Enhancement for Chronic Pain

A clinical trial of Chronic Pain, sponsored by RAND.

Completed
Registry status
11,146
Enrollment target
1
Study location

NCT04426812 is a study of Chronic Pain that has completed, run by RAND. The registered enrollment target is 11,146 participants, above the 735-participant average among 301 other Chronic Pain trials with a reported enrollment target (1416% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04426812, a study of Chronic Pain, has completed, sponsored by RAND.

COMPLETED
Registry status
11,146 participants
Enrollment target
1
Study location

Study Summary

Many complementary and integrative health approaches have been shown to be effective for chronic pain and included in guidelines. This evidence of effectiveness is built on hundreds of studies representing millions of research dollars, and the ability to analyze and better compare results across these studies is essential to obtain the full value of this investment. However, useful across-study comparisons which would allow better understanding and targeting of these interventions are hampered by at least two challenges: the lack of common outcome measures and the inability to meaningfully stratify or classify patients. The first two Aims of this study each address one of these two challenges. The last Aim takes advantage of this study to further test the viability of MTurk as a data collection platform. Specific Aim 1 addresses the lack of common outcome measures. This Aim is to develop and evaluate links or crosswalks between the PROMIS-29 and other common (legacy) measures used for chronic pain so that the results of studies using different measures can be compared. Our hypothesis here is that we will be able to create some sort of linkage between PROMIS and legacy measures that will allow for each pair estimates of one to be made from the other. Specific Aim 2 addresses the inability to meaningfully stratify or subclassify chronic pain patients. This Aim is to evaluate and refine the chronic pain impact stratification scheme (ISS) proposes by the NIH Research Task Force on chronic low back pain, which is based on 9 PROMIS-29 items. Our hypothesis here is that the ISS can be refined so that it can identify subgroups of chronic pain patients with different levels of morbidity and different needs for treatment. Specific Aim 3 addresses the potential for more efficient data collection using the MTurk platform. This Aim is to evaluate MTurk as a cost- and time-efficient method to collect quality data on individuals with chronic pain. Our hypothesis here is that w

Conditions Studied

Interventions

  • OTHER No intervention; just data collection

Study Locations (1)

California

  • Online recruitment only - nationwide - Santa Monica

Trial Details

FieldValue
Enrollment Target 11,146 participants
Start Date 2021-08-30
Est. Completion 2024-11-25

Sponsor

RAND

78 total trials

What the Registry Record Tells You About NCT04426812

The ClinicalTrials.gov registry entry for NCT04426812 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11,146 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 735-participant average among 301 other Chronic Pain trials with a reported enrollment target (1416% higher). The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which No intervention; just data collection is the first listed.

NCT04426812 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04426812 about?

NCT04426812 is a clinical study titled "Measuring Chronic Pain Impact: Measurement Enhancement for Chronic Pain". Many complementary and integrative health approaches have been shown to be effective for chronic pain and included in guidelines. This evidence of effectiveness is built on hundreds of studies representing millions of research dollars, and the ability to analyze and better compare results across the...

What is the current status of trial NCT04426812?

This trial is currently completed. The enrollment target is 11,146 participants. The study started on 2021-08-30. Estimated completion is 2024-11-25.

What conditions does trial NCT04426812 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT04426812?

The interventions under investigation include: No intervention; just data collection (OTHER).

Who is sponsoring clinical trial NCT04426812?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04426812 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.